CovidChloroV1, Main, Curation, bibRecord, 001150

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.

Identifieur interne : 001150 ( Main/Curation ); précédent : 001149; suivant : 001151

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.

Auteurs : Carmel M. Mceniery [Royaume-Uni] ; Marie Fisk [Royaume-Uni] ; Karen Miles [Royaume-Uni] ; Fotini Kaloyirou [Royaume-Uni] ; Annette Hubsch [Royaume-Uni] ; Jane Smith [Royaume-Uni] ; Ian B. Wilkinson [Royaume-Uni] ; Joseph Cheriyan [Royaume-Uni]

Source :

Trials [ 1745-6215 ] ; 2020.

RBID : pubmed:32665001

Abstract

An amendment to this paper has been published and can be accessed via the original article.

DOI: 10.1186/s13063-020-04578-7
PubMed: 32665001
PubMed Central: PMC7358337

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001150

Links to Exploration step

pubmed:32665001

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</title>
<author><name sortKey="Mceniery, Carmel M" sort="Mceniery, Carmel M" uniqKey="Mceniery C" first="Carmel M" last="Mceniery">Carmel M. Mceniery</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fisk, Marie" sort="Fisk, Marie" uniqKey="Fisk M" first="Marie" last="Fisk">Marie Fisk</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Miles, Karen" sort="Miles, Karen" uniqKey="Miles K" first="Karen" last="Miles">Karen Miles</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaloyirou, Fotini" sort="Kaloyirou, Fotini" uniqKey="Kaloyirou F" first="Fotini" last="Kaloyirou">Fotini Kaloyirou</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hubsch, Annette" sort="Hubsch, Annette" uniqKey="Hubsch A" first="Annette" last="Hubsch">Annette Hubsch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smith, Jane" sort="Smith, Jane" uniqKey="Smith J" first="Jane" last="Smith">Jane Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wilkinson, Ian B" sort="Wilkinson, Ian B" uniqKey="Wilkinson I" first="Ian B" last="Wilkinson">Ian B. Wilkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cheriyan, Joseph" sort="Cheriyan, Joseph" uniqKey="Cheriyan J" first="Joseph" last="Cheriyan">Joseph Cheriyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32665001</idno>
<idno type="pmid">32665001</idno>
<idno type="doi">10.1186/s13063-020-04578-7</idno>
<idno type="pmc">PMC7358337</idno>
<idno type="wicri:Area/Main/Corpus">001150</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001150</idno>
<idno type="wicri:Area/Main/Curation">001150</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001150</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</title>
<author><name sortKey="Mceniery, Carmel M" sort="Mceniery, Carmel M" uniqKey="Mceniery C" first="Carmel M" last="Mceniery">Carmel M. Mceniery</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fisk, Marie" sort="Fisk, Marie" uniqKey="Fisk M" first="Marie" last="Fisk">Marie Fisk</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Miles, Karen" sort="Miles, Karen" uniqKey="Miles K" first="Karen" last="Miles">Karen Miles</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kaloyirou, Fotini" sort="Kaloyirou, Fotini" uniqKey="Kaloyirou F" first="Fotini" last="Kaloyirou">Fotini Kaloyirou</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hubsch, Annette" sort="Hubsch, Annette" uniqKey="Hubsch A" first="Annette" last="Hubsch">Annette Hubsch</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Smith, Jane" sort="Smith, Jane" uniqKey="Smith J" first="Jane" last="Smith">Jane Smith</name>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Wilkinson, Ian B" sort="Wilkinson, Ian B" uniqKey="Wilkinson I" first="Ian B" last="Wilkinson">Ian B. Wilkinson</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cheriyan, Joseph" sort="Cheriyan, Joseph" uniqKey="Cheriyan J" first="Joseph" last="Cheriyan">Joseph Cheriyan</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge University Hospitals NHS, Foundation Trust, Cambridge</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Trials</title>
<idno type="eISSN">1745-6215</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">An amendment to this paper has been published and can be accessed via the original article.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32665001</PMID>
<DateRevised><Year>2020</Year>
<Month>07</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>21</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
<Month>07</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Trials</Title>
<ISOAbbreviation>Trials</ISOAbbreviation>
</Journal>
<ArticleTitle>Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.</ArticleTitle>
<Pagination><MedlinePgn>641</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-020-04578-7</ELocationID>
<Abstract><AbstractText>An amendment to this paper has been published and can be accessed via the original article.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McEniery</LastName>
<ForeName>Carmel M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fisk</LastName>
<ForeName>Marie</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK. mf503@medschl.cam.ac.uk.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK. mf503@medschl.cam.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Miles</LastName>
<ForeName>Karen</ForeName>
<Initials>K</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kaloyirou</LastName>
<ForeName>Fotini</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hubsch</LastName>
<ForeName>Annette</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Smith</LastName>
<ForeName>Jane</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wilkinson</LastName>
<ForeName>Ian B</ForeName>
<Initials>IB</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cheriyan</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Division of Experimental Medicine & Immunotherapeutics, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge University Hospitals NHS, Foundation Trust, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Cambridge Clinical Trials Unit, University of Cambridge, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016425">Published Erratum</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>07</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Trials</MedlineTA>
<NlmUniqueID>101263253</NlmUniqueID>
<ISSNLinking>1745-6215</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="ErratumFor"><RefSource>Trials. 2020 Jul 2;21(1):604</RefSource>
<PMID Version="1">32616067</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32665001</ArticleId>
<ArticleId IdType="doi">10.1186/s13063-020-04578-7</ArticleId>
<ArticleId IdType="pii">10.1186/s13063-020-04578-7</ArticleId>
<ArticleId IdType="pmc">PMC7358337</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Trials. 2020 Jul 2;21(1):604</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32616067</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001150 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001150 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:32665001
   |texte=   Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:32665001" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.

Correction to: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki